NO992102L - Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen - Google Patents
Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingenInfo
- Publication number
- NO992102L NO992102L NO992102A NO992102A NO992102L NO 992102 L NO992102 L NO 992102L NO 992102 A NO992102 A NO 992102A NO 992102 A NO992102 A NO 992102A NO 992102 L NO992102 L NO 992102L
- Authority
- NO
- Norway
- Prior art keywords
- composition
- peptide composition
- well
- peptide
- cancer vaccine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 229940022399 cancer vaccine Drugs 0.000 title 1
- 238000009566 cancer vaccine Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001164—GTPases, e.g. Ras or Rho
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19992102A NO309798B1 (no) | 1999-04-30 | 1999-04-30 | Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen |
ARP000102059A AR023806A1 (es) | 1999-04-30 | 2000-04-28 | Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas |
PCT/NO2000/000142 WO2000066153A1 (en) | 1999-04-30 | 2000-04-28 | RAS ONCOGEN p21 PEPTIDE VACCINES |
EP00925746A EP1173199A1 (en) | 1999-04-30 | 2000-04-28 | RAS ONCOGEN p21 PEPTIDE VACCINES |
AU44389/00A AU4438900A (en) | 1999-04-30 | 2000-04-28 | Ras oncogen p21 peptide vaccines |
CA002372187A CA2372187A1 (en) | 1999-04-30 | 2000-04-28 | Ras oncogen p21 peptide vaccines |
JP2000615037A JP2002543149A (ja) | 1999-04-30 | 2000-04-28 | RASオンコージンp21ペプチドワクチン |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19992102A NO309798B1 (no) | 1999-04-30 | 1999-04-30 | Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen |
Publications (3)
Publication Number | Publication Date |
---|---|
NO992102D0 NO992102D0 (no) | 1999-04-30 |
NO992102L true NO992102L (no) | 2000-10-31 |
NO309798B1 NO309798B1 (no) | 2001-04-02 |
Family
ID=19903274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19992102A NO309798B1 (no) | 1999-04-30 | 1999-04-30 | Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1173199A1 (no) |
JP (1) | JP2002543149A (no) |
AR (1) | AR023806A1 (no) |
AU (1) | AU4438900A (no) |
CA (1) | CA2372187A1 (no) |
NO (1) | NO309798B1 (no) |
WO (1) | WO2000066153A1 (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836684B1 (fr) * | 2002-03-04 | 2004-12-17 | Inst Nat Sante Rech Med | Peptides ras mutes et leur utilisation en immunotherapie |
WO2004058157A2 (en) * | 2002-12-16 | 2004-07-15 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
MX2008012392A (es) | 2006-03-27 | 2008-12-17 | Globeimmune Inc | Mutacion de ras, y composiciones y metodos relacionados con la misma. |
GB0821616D0 (en) | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
AU2010290931B2 (en) * | 2009-09-03 | 2014-02-06 | Pfizer Vaccines Llc | PCSK9 vaccine |
US9115402B2 (en) | 2010-05-14 | 2015-08-25 | Dana-Farber Cancer Institute, Inc. | Compositions and methods of identifying tumor specific neoantigens |
CN102060929A (zh) * | 2010-06-07 | 2011-05-18 | 夏书奇 | T细胞免疫平衡肽 |
WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
AU2014363643B2 (en) | 2013-12-09 | 2019-01-03 | Targovax Solutions AS | A peptide mixture |
CA2934073A1 (en) | 2013-12-20 | 2015-06-25 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
RU2700929C2 (ru) * | 2014-05-06 | 2019-09-24 | Тарговакс Аса | Пептидная вакцина, включающая пептид ras, содержащий мутации, и химиотерапевтический агент |
EP3234193B1 (en) | 2014-12-19 | 2020-07-15 | Massachusetts Institute of Technology | Molecular biomarkers for cancer immunotherapy |
EP3757211A1 (en) | 2014-12-19 | 2020-12-30 | The Broad Institute, Inc. | Methods for profiling the t-cell-receptor repertoire |
RU2020132040A (ru) * | 2015-05-20 | 2020-10-12 | Те Брод Инститьют Инк. | Общие неоантигены |
MX2017015927A (es) * | 2015-06-16 | 2018-04-18 | Targovax Asa | Fragmentos mutantes de proteina ras. |
WO2018140391A1 (en) | 2017-01-24 | 2018-08-02 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
CN117224710A (zh) | 2017-02-01 | 2023-12-15 | 莫得纳特斯公司 | 编码活化致癌基因突变肽的免疫调节治疗性mrna组合物 |
US11771749B2 (en) | 2017-02-03 | 2023-10-03 | The Medical College Of Wisconsin, Inc. | KRAS peptide vaccine compositions and method of use |
WO2019126186A1 (en) | 2017-12-18 | 2019-06-27 | Neon Therapeutics, Inc. | Neoantigens and uses thereof |
CN114681600A (zh) * | 2018-10-19 | 2022-07-01 | 杭州纽安津生物科技有限公司 | 通用性多肽疫苗及其在制备治疗/预防胰腺癌药物中的应用 |
WO2020145222A1 (ja) * | 2019-01-07 | 2020-07-16 | 地方独立行政法人神奈川県立病院機構 | 新規ネオアンチゲン及びそれらを用いたがん免疫治療薬 |
IL266728B (en) * | 2019-05-19 | 2020-11-30 | Yeda Res & Dev | Identification of recurrent mutant neopeptides |
AU2021223703A1 (en) * | 2020-02-19 | 2022-08-25 | Aelin Therapeutics | Molecules targeting proteins |
JP2023516137A (ja) * | 2020-02-19 | 2023-04-18 | エイリン・セラピューティクス | Rasタンパク質を標的化する分子 |
WO2022219152A1 (en) * | 2021-04-16 | 2022-10-20 | Oblique Therapeutics Ab | Kras antibodies |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4957859A (en) * | 1988-02-16 | 1990-09-18 | Hoffmann-La Roche Inc. | Antibodies for transforming ras protein |
GB9103974D0 (en) * | 1991-02-26 | 1991-04-10 | Norsk Hydro As | Therapeutically useful peptides or peptide fragments |
ATE220718T1 (de) * | 1996-04-19 | 2002-08-15 | Us Gov Sec Health | Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizyten |
GB9620350D0 (en) * | 1996-09-30 | 1996-11-13 | Maudsley David J | Cancer vaccine |
GB2328689A (en) * | 1997-08-27 | 1999-03-03 | Norsk Hydro As | Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer |
-
1999
- 1999-04-30 NO NO19992102A patent/NO309798B1/no not_active IP Right Cessation
-
2000
- 2000-04-28 CA CA002372187A patent/CA2372187A1/en not_active Abandoned
- 2000-04-28 EP EP00925746A patent/EP1173199A1/en not_active Withdrawn
- 2000-04-28 JP JP2000615037A patent/JP2002543149A/ja active Pending
- 2000-04-28 AR ARP000102059A patent/AR023806A1/es unknown
- 2000-04-28 AU AU44389/00A patent/AU4438900A/en not_active Abandoned
- 2000-04-28 WO PCT/NO2000/000142 patent/WO2000066153A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000066153A1 (en) | 2000-11-09 |
EP1173199A1 (en) | 2002-01-23 |
NO309798B1 (no) | 2001-04-02 |
NO992102D0 (no) | 1999-04-30 |
CA2372187A1 (en) | 2000-11-09 |
AR023806A1 (es) | 2002-09-04 |
JP2002543149A (ja) | 2002-12-17 |
AU4438900A (en) | 2000-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992102L (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
NL1015859A1 (nl) | Farmaceutische preparaten. | |
NO20032438D0 (no) | Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene | |
DK1210113T3 (da) | Kombinerede vaccinepræparater | |
ITTO20010005A0 (it) | Formulazione farmaceutica. | |
NO20033556D0 (no) | Farmasöytiske preparater | |
EE200200038A (et) | Konservitud farmatseutilised preparaadid | |
TR199901077A3 (tr) | Ispençiyari formülasyonlar. | |
NO20015175L (no) | Farmasöytisk sammensetning | |
DE60045324D1 (de) | Impfstoffzusammensetzung | |
ZA200407868B (en) | 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations. | |
NO20005146D0 (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
NO20006138D0 (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
NO20022606D0 (no) | Farmasöytiske kombinasjoner | |
NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
IT1311921B1 (it) | Composti farmaceutici. | |
NO20022022D0 (no) | N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
NO983472D0 (no) | Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene | |
DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
DE69926012D1 (de) | Arzneizubereitungen | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
NO20014692L (no) | 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav | |
NO20016430D0 (no) | Farmasöytisk kompleks | |
AR025867A1 (es) | Formulacion portasdora farmaceutica | |
DE69906934D1 (de) | Arzneizubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS POSTBOKS 765 SENTRUM OSLO, 0106 NO |
|
MM1K | Lapsed by not paying the annual fees |